Cargando…
Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma
The most common cause of primary hyperparathyroidism (PHPT) is a solid parathyroid adenoma. Less than 2% of cases of PHPT are caused by cystic parathyroid adenomas formed from degeneration of pre-existing solid parathyroid adenomas. Cystic parathyroid adenomas are non-functional in over 90% of cases...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481103/ https://www.ncbi.nlm.nih.gov/pubmed/34646632 http://dx.doi.org/10.7759/cureus.17577 |
_version_ | 1784576609741701120 |
---|---|
author | Win, George M Gusov, Timur Marium, FNU Gardner, Michael J |
author_facet | Win, George M Gusov, Timur Marium, FNU Gardner, Michael J |
author_sort | Win, George M |
collection | PubMed |
description | The most common cause of primary hyperparathyroidism (PHPT) is a solid parathyroid adenoma. Less than 2% of cases of PHPT are caused by cystic parathyroid adenomas formed from degeneration of pre-existing solid parathyroid adenomas. Cystic parathyroid adenomas are non-functional in over 90% of cases. In this case we describe management of a 56-year-old man with acute-onset polydipsia, polyuria, xerostomia, nausea, and constipation. Serum chemistry upon admission revealed hypercalcemia, hyperparathyroidism, and reduced serum phosphorus. Neck sonogram revealed a predominantly anechoic lesion later confirmed by pathology to be a cystic parathyroid adenoma in the right thyroid lobe. Sestamibi scan did not show uptake in parathyroid gland, and parathyroid hormone (PTH) was elevated in fine-needle aspiration sample. Otolaryngology removed the cystic lesion via surgical excision, which led to normalization of PTH level. This case demonstrates the importance of evaluation of cystic components for PTH levels and if confirmed should be treated as a parathyroid adenoma. |
format | Online Article Text |
id | pubmed-8481103 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-84811032021-10-12 Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma Win, George M Gusov, Timur Marium, FNU Gardner, Michael J Cureus Endocrinology/Diabetes/Metabolism The most common cause of primary hyperparathyroidism (PHPT) is a solid parathyroid adenoma. Less than 2% of cases of PHPT are caused by cystic parathyroid adenomas formed from degeneration of pre-existing solid parathyroid adenomas. Cystic parathyroid adenomas are non-functional in over 90% of cases. In this case we describe management of a 56-year-old man with acute-onset polydipsia, polyuria, xerostomia, nausea, and constipation. Serum chemistry upon admission revealed hypercalcemia, hyperparathyroidism, and reduced serum phosphorus. Neck sonogram revealed a predominantly anechoic lesion later confirmed by pathology to be a cystic parathyroid adenoma in the right thyroid lobe. Sestamibi scan did not show uptake in parathyroid gland, and parathyroid hormone (PTH) was elevated in fine-needle aspiration sample. Otolaryngology removed the cystic lesion via surgical excision, which led to normalization of PTH level. This case demonstrates the importance of evaluation of cystic components for PTH levels and if confirmed should be treated as a parathyroid adenoma. Cureus 2021-08-30 /pmc/articles/PMC8481103/ /pubmed/34646632 http://dx.doi.org/10.7759/cureus.17577 Text en Copyright © 2021, Win et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Endocrinology/Diabetes/Metabolism Win, George M Gusov, Timur Marium, FNU Gardner, Michael J Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma |
title | Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma |
title_full | Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma |
title_fullStr | Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma |
title_full_unstemmed | Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma |
title_short | Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma |
title_sort | primary hyperparathyroidism secondary to a sestamibi-negative cystic parathyroid adenoma |
topic | Endocrinology/Diabetes/Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481103/ https://www.ncbi.nlm.nih.gov/pubmed/34646632 http://dx.doi.org/10.7759/cureus.17577 |
work_keys_str_mv | AT wingeorgem primaryhyperparathyroidismsecondarytoasestamibinegativecysticparathyroidadenoma AT gusovtimur primaryhyperparathyroidismsecondarytoasestamibinegativecysticparathyroidadenoma AT mariumfnu primaryhyperparathyroidismsecondarytoasestamibinegativecysticparathyroidadenoma AT gardnermichaelj primaryhyperparathyroidismsecondarytoasestamibinegativecysticparathyroidadenoma |